CLDX Projected Dividend Yield
Celldex Therapeutics, Inc. ( NASDAQ : CLDX )Celldex Therapeutics, Inc. is a biopharmaceutical company. Co. is focused on exploring the science of mast cell biology and the development of transformative therapeutics for patients. Its drug candidates include monoclonal and bispecific antibodies designed to address mast cell mediated diseases for which available treatments are inadequate. Its Barzolvolimab, a monoclonal antibody that specifically binds the KIT receptor and potently inhibits its activity, which is studied across multiple mast cell driven diseases, including Chronic Urticarias, Prurigo Nodularis and Eosinophilic Esophagitis. 20 YEAR PERFORMANCE RESULTS |
CLDX Dividend History Detail CLDX Dividend News CLDX Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |